Target intelligence / Profile preview

Glycoprotein H–Glycoprotein L complex (gH/gL)

Target
gH/gL
Molecular classification
Viral fusion complex (unique among enveloped viruses[5]), Heterodimeric viral glycoprotein, Envelope protein complex
01

Overview

The glycoprotein H–glycoprotein L complex (gH/gL) is a stable heterodimeric protein complex found on the surface of all herpesviruses, including herpes simplex virus (HSV), Epstein–Barr virus (EBV), human cytomegalovirus (HCMV), and human herpesvirus 7 (HHV-7), among others[1][2][3][4][5][7]. Both gH and gL are glycoproteins: gH is a transmembrane protein with a large ectodomain and a single transmembrane region, while gL lacks a transmembrane segment and acts as a scaffold for proper folding and trafficking of gH[1][2][3][4]. The gH/gL complex does not directly bind cell receptors or act as a viral fusogen; instead, it functions as a structural adapter that receives triggering signals from viral receptor-binding proteins and then activates gB, the primary fusion protein, to drive membrane fusion[1][3][5]. Crystal structures reveal extensive hydrophobic interfaces and specific domain contacts essential for stability and function[1][3][6]. The complex is highly conserved among herpesviruses and is a major target of the humoral immune response[7]. Disrupting gH/gL function impedes herpesvirus entry, making it an attractive — but still mostly preclinical — target for antivirals and vaccines[1][7].

Other names
Glycoprotein H–glycoprotein L heterodimergH–gLHerpesvirus fusion complex (less common)
02

Mechanism of action

Blockade of gH/gL interaction with gB (neutralization of infection by inhibiting formation of the fusion complex[1][7]); Inhibition of membrane fusion and viral entry (by disrupting gH/gL function[1][7])

03

Biological functions

Membrane fusion (facilitates fusion of viral and host membranes via activation of gB[1][4][5])Cell entry (essential for herpesvirus entry into host cells[4][5])Signal transduction to activate gB[1][5]Protein folding and trafficking (gL stabilizes and scaffolds gH[1][4])
04

Disease associations

Infection (required for herpesvirus infectivity[2][4][5])
05

Safety considerations

None documented for direct targeting, but optimal selectivity remains a challenge due to cross-reactivity among herpesviruses.Possible immune-related side effects if used as vaccine antigens.
06

Interacting drugs

Neutralizing antibodies against gH/gL (e.g., anti-gH/gL monoclonal antibodies[1][7])

1 more in the full profile.

07

Biomarkers

Anti-gH/gL antibody titers (useful in vaccine or immune response monitoring[7])

Beyond the preview

Go deeper on Glycoprotein H–Glycoprotein L complex (gH/gL).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glycoprotein H–Glycoprotein L complex (gH/gL).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call